The global 3D cell culture market is poised to reach $ 2,750 million by 2020, at an estimated CAGR of 30.6% from 2015 to 2020.
Cosmetics market and regenerative medicine offers huge potential to the growth of this market in the coming five years, hence these are looked upon as promising opportunity areas for 3D cell culture market in future. However, conservative outlook of the researchers to adapt to 3D cell culture market at a rapid pace, and lack of consistency in products between wells and batches of cell culture are factors restraining the growth of the market.
Browse full-In depth report on www.meticulousresearch.com/product…outlook2015-2020/
The research report on the global 3D cell culture market provides a comprehensive analysis of the global market with a regional level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major technologies and product segments such as scaffold-free platforms, scaffold- based platforms, bioreactors, and microchips.
On the basis of application, the 3D cell culture market is segmented into five segments namely, clinical applications, drug discovery & toxicology, research (academic & basic laboratories), stem cell research, and tissue engineering. Market size estimates and forecasts for the period 2013 to 2020 has been provided for each segment and its sub-segment, in terms of USD million, calculating growth rates from 2015 to 2020, considering 2014 as the base year for calculations.
The global 3D cell culture market is segmented by geography as North America, Europe, Asia, and Rest of the World (RoW). These regions analyzed with a detailed qualitative and quantitative insights.
In terms of technology, scaffold-based technology which includes hydrogels, porous scaffolds, and fibrous scaffolds is set to grow rapidly in the coming five years. The largest application area for 3D cell culture is clinical applications such as personalized medicines and cancer research.
3D cell culture model plays a vital role in cancer research. A number of cancer model systems are available to investigate disease mechanisms and to screen therapies.
North America dominates the 3D cell culture market in the year 2015, followed by Europe and Asia. Asia is slated to witness highest growth rate in the coming five years with China, Japan, Taiwan, India, Malaysia, and Singapore witnessing significant growth in the 3D cell culture market, as a result of their economic development, rising awareness regarding cancer in these countries, huge production of drugs in this region, and the growing focus of 3D cell culture players in these markets.
As research demands have become increasingly complex, there is a rising need for better 3D cell culture techniques. Citing this, various companies are introducing 3D cell culture products using their own technologies.
This competitive approach has led to rapid development of 3D cell culture products in the market. The 3D cell culture market is fragmented showing the presence of few large players and many small players.
The major players in the global 3D cell culture market are BD Biosciences, Thermo Fisher Scientific, Corning Life Sciences, Sigma-Aldrich, and Lonza Group, 3D Biomatrix, Inc., 3D Biotek LLC, Reinnervate Ltd., Insphero AG, and Nanofiber Solutions, LLC among others.
Category: Market Research Publishers and RetailersCompany profile: Meticulous Research is one of the leading independent full service global market research and consulting companies focusing on medical devices, biotechnology, healthcare IT, pharmaceuticals, food and beverages, and agriculture domains. Meticulous Research produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and Middle East and Africa regions.
For more information: